A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure

Clinical trial NCT05451329 · COMPLETED

Trial details

NCT number: NCT05451329
Sponsor: VivaVision Biotech, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glaucoma, Open-Angle

Start date: 2022-07-12
Primary completion: 2022-12-22
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.